1. Subjective outcome measurement_a primer

   • Mary Patricia Tully
   • Judith A. Cantrill

   OriginalPaper Pages: 101 - 109

2. Academic detailing improves identification and reporting of adverse drug events

   • Raymond G. Schlienger
   • Thomas F. Lüscher
   • Ronald A. Schoenenberger

   OriginalPaper Pages: 110 - 115

3. Asthma exacerbations during first therapy with long acting β2‐agonists

   • C.M.J.M. Gerrits
   • R.M.C. Herings
   • J‐W.J. Lammers

   OriginalPaper Pages: 116 - 119

4. The quality of Dutch hospital drug formularies: Evaluation of technical features and organisational information

   • R. Fijn
   • S.A.G. Engels
   • C.J. De Blaey

   OriginalPaper Pages: 120 - 126

5. Technicians or patient advocates? − still a valid question

   • Anna Birna Almarsd¢ttir
   • Janine Marie Morgall

   OriginalPaper Pages: 127 - 131

6. Antidepressant drug choice for first users in two regions in the Netherlands

   • A.C.G. Egberts
   • M. Veenstra
   • L.T.W. de Jong - van den Berg

   OriginalPaper Pages: 132 - 136

7. Physico‐chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers

   • Judith Thiesen
   • Irene Krämer

   OriginalPaper Pages: 137 - 141

8. The role of the French community pharmacist in drug dispensing

   • G. Ghamba
   • G. Bauguil
   • J. Gallezot

   OriginalPaper Pages: 142 - 143

9. Long‐term stability of morphine and bupivacaine mixture for spinal use

   • C.M. Essink-Tjebbes
   • D.M. Burger
   • Y.A. Hekster

   OriginalPaper Pages: 144 - 146

10. Proceedings – ESCP27 th European Symposium on Clinical Pharmacy Evidence-Based Pharmaceutical Care, 26-28 October 1998, Jerusalem, Israel

    OriginalPaper Pages: 147 - 166